TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Biotage AB
Closing information (x1000 DKK)
| Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Turnover |
1,250,658
|
1,046,453
|
895,826 |
| Financial expenses |
27,539
|
9,355
|
8,726 |
| Earnings before taxes |
203,517
|
232,545
|
195,598 |
| EBITDA |
310,985
|
286,672
|
252,315 |
| Total assets |
3,312,027
|
1,562,998
|
1,448,446 |
| Current assets |
971,913
|
688,948
|
562,800 |
| Current liabilities |
470,844
|
276,649
|
225,411 |
| Equity capital |
2,456,314
|
1,093,898
|
996,897 |
| - share capital |
75,228
|
62,146
|
66,896 |
| Employees (average) |
674
|
517
|
497 |
Financial ratios
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Solvency |
74.2%
|
70.0%
|
68.8% |
| Turnover per employee |
1,856
|
2,024
|
1,802 |
| Profit as a percentage of turnover |
16.3%
|
22.2%
|
21.8% |
| Return on assets (ROA) |
7.0%
|
15.5%
|
14.1% |
| Current ratio |
206.4%
|
249.0%
|
249.7% |
| Return on equity (ROE) |
8.3%
|
21.3%
|
19.6% |
| Change turnover |
198,816
|
223,190
|
101,596 |
| Change turnover % |
19%
|
27%
|
13% |
| Chg. No. of employees |
157
|
20
|
34 |
| Chg. No. of employees % |
30%
|
4%
|
7% |
Total value of public sale
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.